Milk Fat Intake and Metabolic Health Markers

Status unconfirmed · Not applicable

Conditions studied: Insulin Sensitivity, Type 2 Diabetes

In brief

This study investigates the effects of bioactive fatty acids in full fat dairy (whole yogurt), on insulin action, calorie needs, blood lipids, immune function, and body composition in normal and overweight male and female volunteers.

Key facts

Study ID

NCT02659748

Run by

University of Vermont Medical Center

People needed

21

Starts

2014-01-01

Expected to finish

2016-12-01

Last updated by the study team

2016-10-26

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good general health and not expecting major lifestyle changes while on study
• BMI between 18.5 and 29.9 kg/m2
• Willing to follow the study coordinator's and dietitian's instructions

You may not qualify if…

• Subject with any chronic disease, inflammatory disease and previous diagnosis of HIV or hepatitis C
• Subjects with diabetes (type 1 or 2)
• Subjects with insulin resistance
• Subjects who manifest metabolic syndrome based on aggregate clinical signs
• Intolerance to dairy foods
• Use of prescription medication (except oral contraceptives)
• On medically prescribed diets or following a diet
• Taking supplements that could obscure our ability to detect diet effects
• Frequent use of over-the-counter medication
• Habitual use of tobacco or controlled substances such as cannabis
• Low-density lipoprotein cholesterol (LDL-C) or triacylglycerol (TAG) concentrations <5th or >95th percentile for age
• Participation on regular basis in competitive sports or habitual aerobic exercise training, which we will arbitrarily define as consisting of > 3 bouts/wk of aerobic exercise (unable to speak comfortably) for more than 20 min
• Women who are pregnant or lactating or planning to get pregnant
• Allergies or significant food preferences or restrictions that would interfere with diet adherence
• Lifestyle or schedule incompatible with the study protocol
• Psychiatric or behavioral conditions that in the view of the principal investigator may present a safety hazard to the participant or interfere with study participation or the ability to follow the intervention protocol
• Heart condition

Where it is running

• Clinical Research Center, University of Vermont Medical Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.